SNDY Stock UPDATES Solos Endoscopy Inc (SNDY) 0.0006 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Solos Endoscopy Inc (SNDY) 0.0006 $SNDY

Solos Endoscopy Reports Financial Results for Period Ended June 30, 2014
ACCESSWIRE - Mon Aug 18, 11:00AM CDT
BOSTON, MA / ACCESSWIRE / August 18, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the United States, reported sales and earnings results for period ended June 30, 2014, and its quarterly disclosure statement on OTC Markets.com.

Solos Endoscopy Posts Shareholder Update on OTC Markets.com
ACCESSWIRE - Wed Jul 23, 9:23AM CDT
BOSTON, MA / ACCESSWIRE / July 23, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.

Solos Endoscopy Reports Financial Results for Period Ended December 31, 2013
Marketwire - Tue Apr 01, 9:05AM CDT
Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, reported sales and earnings results for the period ended December 31, 2013.

Solos Endoscopy to Begin Distribution of Its Endoscopic Instruments in Canada
Marketwire - Thu Feb 20, 10:41AM CST
Solos Endoscopy, Inc. (OTC Pink: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has commenced negotiations with a Canadian distributor to sell its endoscopic instruments including the MammoView(R) devices in Canada.

Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC
PR Newswire - Fri Jan 24, 10:32AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's subcutaneous (SC) formulation of MabThera® (rituximab) using Halozyme's recombinant human hyaluronidase (rHuPH20) for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL).

Pain Therapeutics - Drugs, Markets and Companies
PR Newswire - Thu Jan 16, 1:00PM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics) has announced the addition of a new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Solos Endoscopy Completes Stage 2 of its ISO 13485 Audit with TUV SUD America
ACCESSWIRE - Thu Aug 22, 8:06AM CDT
BOSTON, MA, August 22, 2013 - (Accesswire) - Solos Endoscopy, Inc. (OTCPink: SNDY) is pleased to announce that TUV SUD America has completed its Stage 2 ISO 13485 Audit with Solos Endoscopy on August 16, 2013. Solos Endoscopy will be certified to ISO 13485:2003, the internationally-recognized standard for quality systems for medical device manufacturers, once it reviews and resolves any corrective actions that were discovered during the final audit.

Solos Endoscopy Reports 2nd Quarter Results
ACCESSWIRE - Wed Aug 14, 11:15AM CDT
Company Posts Financials for Period Ended June 30, 2013, President's Letter to Shareholders

Solos Endoscopy Retains Emergo Group to be the Authorized Representative for the Importation of Solos Instruments into Europe
ACCESSWIRE - Fri Aug 02, 8:06AM CDT
BOSTON, August 2, 2013 - Solos Endoscopy, Inc. (OTC PINK: SNDY) is pleased to announce that the Company has retained Emergo Group to act as the Company's authorized representative in Europe. Emergo Group will provide Solos assistance related to communications with authorities and importation of Solos instruments into Europe.

Solos Endoscopy's MammoView(R) System Offers Women Early Breast Cancer Detection
ACCESSWIRE - Thu Jul 18, 12:01PM CDT
BOSTON, MA, July 18, 2013 - (eTeligis via ACCESSWIRE) - Solos Endoscopy, Inc. (OTC PINK: SNDY) is pleased to announce that the Company's MammoView(R) Breast Endoscopy System can aid in giving women the best prognosis for recovery by detecting breast cancer at an earlier stage than conventional methods (http://www.solosendoscopy.com/ductoscope-sell-sheet-final.pdf).

Solos Endoscopy and TUV SUD America Schedule Stage 2 ISO 13485 Audit for August 16, 2013
PR Newswire - Wed Jun 12, 9:06AM CDT
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company and TUV SUD America has scheduled its Stage 2 ISO 13485 Audit for August 16, 2013.

Solos Endoscopy Reports Full Year 2012 Results
PR Newswire - Wed May 15, 8:36AM CDT
Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, reported sales and earnings results for the full year ended December 31, 2012.

Solos Endoscopy Management Announces Goals for 2013
PR Newswire - Fri Jan 04, 9:16AM CST
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company plans to continue its progress in 2013 as its management has announced its goals for moving forward in the New Year.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

TDH's First-Half Revenue Grew, but Margins Vanished

Updated Category News Views 106

A rental business can add tenants and still march backward, and TDH Holdings just demonstrated the ugly math. For the six months ended June 30, 2026, revenue from continuing operations rose 26.45% to $0.74 million. That is the pleasant number, and it deserves exactly one polite nod. Everything beneath it looks far less comfortable: costs climbed faster than revenue, gross...

Continue Reading
Texas Plumbing Award Signals Local Service Discipline

Updated Category News Views 90

A clogged main line is not glamorous, but it is where a local service reputation gets tested for real. Neighborhood Plumbing and Drain has been named a 2026 Best of Texas Award winner in the Plumbing Contractors category, a recognition that matters less as a trophy than as a public signal: customers around Central Texas have noticed the outfit. For anyone watching the...

Continue Reading
Caregiver Strategy Puts a Hard Truth on the Table Today

Updated Category News Views 57

Sixty-three million people carrying care responsibilities is not a side issue; it is a national load-bearing wall. The 2026 National Strategy to Support Family Caregivers arrives with that reality plainly in view, and frankly, it is overdue for the country to treat family care as core infrastructure rather than a private household problem somebody is expected to absorb...

Continue Reading
BET's HBCU Basketball Bet Is Bigger Than Six Games

Updated Category News Views 46

December television usually hands the microphone to the same old basketball machinery, which makes BET putting HBCU hoops in primetime feel overdue rather than merely promotional. Beginning December 3 at 8:00 p.m. ET, BET and Straight Shooter Media will air a six-game series built around Howard University and a rotating slate of opponents. The opener is Grambling State...

Continue Reading
RBI Heads to Morgan Stanley With Plenty to Explain

Updated Category News Views 63

Two executives, one New York stage, and a short calendar gap give Restaurant Brands International a clean chance to address investors without the usual blizzard of quarterly slides. Chief Executive Officer Josh Kobza and Chief Financial Officer Sami Siddiqui are scheduled for a fireside chat at Morgan Stanley's Global Consumer & Retail Conference on December 2, 2026, at...

Continue Reading
Jeff Stern Turns Travel Photography Into a Sensory Memoir

Updated Category News Views 112

Frost in a mountain tent, fermented mare’s milk in a yurt, and coffee in Vietnamese rice paddies are doing more work here than a thousand polished sunset captions ever could. Jeff Stern’s A Change of Scenery, released by Palmetto Publishing on November 17, 2026, comes from a man who spent more than 25 years building brands and then decided the usual labels around...

Continue Reading
Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 118

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Cloud Optical Demand Is Running Ahead of Supply in 2026

Updated Category News Views 15

Fiber capacity has become the awkward bottleneck nobody can wish away. Dell’Oro Group says the optical transport equipment market expanded 24% year over year in the third quarter of 2026, with large North American cloud providers doing the heavy lifting. More pointedly, optical vendor revenue tied to those cloud customers jumped 75%. That is not a gentle improvement in...

Continue Reading
Saban Center Partnership Gives Health Learning a Lift

Updated Category News Views 82

A dinosaur race may sound like pure kid bait, but the underlying idea is sturdier than that. Cardiac Solutions and the Seale family are backing an interactive health-and-performance exhibit at Tuscaloosa’s planned Saban Center, a project intended to turn questions about movement, fitness, heart rate and oxygen levels into something children can actually touch, test and...

Continue Reading
AltaPointe PATH Outreach Puts Housing Waits in Focus

Updated Category News Views 108

Two years is a brutal length of time to ask somebody without stable housing to wait for an income-based apartment. That number hangs over AltaPointe Health's PATH program in Mobile, Alabama, and it ought to. The organization helped 16 people secure permanent housing in the past fiscal year, a figure that can look small if somebody is just skimming a report. It looks very...

Continue Reading

Top 5 Most Recently Viewed Articles

Kleo Partners with Londis to Revolutionize Retail Convenience

Updated Category News Views 256

Kleo Teams Up with Londis to Improve Convenience Store Operations Kleo, a leading provider of EPOS systems and self-ordering kiosks, is thrilled to announce a new partnership with Londis, one of the premier convenience store chains in the UK. This collaboration marks an important move toward modernizing Londis's operations and enhancing customer experiences through...

Continue Reading
W&T Offshore Sees Production Growth and Impressive Cash Flow

Updated Category News Views 119

W&T Offshore's Third Quarter Performance Highlights W&T Offshore, Inc. (NYSE: WTI) has reported its operational and financial results for the third quarter of 2025. With strong results demonstrating production growth and an impressive cash position, the company declared a dividend of $0.01 per share for the upcoming fourth quarter. Financial Overview The company recorded...

Continue Reading
Examining Sustainability in Grape Seed Extracts Production

Updated Category News Views 172

PLT Health Solutions Unveils Sustainability Report for MegaNatural® Grape Seed Extracts PLT Health Solutions, Inc. has proudly released a comprehensive white paper that delves into the sustainability practices involved in the production of its MegaNatural® grape seed extracts. This insightful document showcases the efforts of California Natural Color, a division of...

Continue Reading
Market Stability Returns as VIX Experiences Significant Drop

Updated Category News Views 126

Understanding the Recent Decline in the VIX The CBOE Volatility Index, commonly known as the VIX, saw a notable decrease of 5%, nearing four-week lows. This decline signifies a shift in market sentiment, reflecting greater stability in investor outlook. The Impact of Political Changes on Volatility With the inauguration of a new U.S. President, the market has reacted...

Continue Reading
AlphaTON Capital Corp. Advances in Cancer Treatment Tokenization

Updated Category News Views 205

AlphaTON Capital Corp. Shares See Significant Gains AlphaTON Capital Corp. (NASDAQ: ATON) has recently garnered attention as its shares experience a notable surge in trading activity. This increase follows the company’s announcement of a non-binding letter of intent to assess the tokenization of single-indication economics for their promising cancer treatment, TT-4,...

Continue Reading